Showing results (601-610 of 642) with videos related to
Sort By:
Pageof 65
Cell Host & Microbe|October 5, 2021
Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunityRita E Chen, Brittany K Smith, John M Errico, et al.Journal of the Neurological Sciences|June 16, 2021
Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questionsKiran T Thakur, Arina Tamborska, Greta K Wood, et al.Cell|March 10, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.Cell Host & Microbe|August 18, 2020
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in MiceJames Brett Case, Paul W Rothlauf, Rita E Chen, et al.Biorxiv : the Preprint Server for Biology|May 11, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.JAMA Network Open|April 17, 2023
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine CancerCalen W Kucera, Chunqiao Tian, Christopher M Tarney, et al.Ebiomedicine|April 4, 2021
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challengeMartin S Winkler, Tomasz Skirecki, Frank M Brunkhorst, et al.Cell Reports|August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.Cell|June 20, 2020
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing AntibodiesAhmed O Hassan, James Brett Case, Emma S Winkler, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2020
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 InfectionWafaa B Alsoussi, Jackson S Turner, James B Case, et al.Pageof 65